Suggested for you
Explore suggested content tailored to your role within the CAR T-cell therapy journey
5-minute watch
ASH 2024
How is MCL managed with CAR T? Results from the EBMT survey
Dr Gloria Iacoboni
3-minute watch
ASH 2024
What approaches are being used to prevent and mitigate CAR T toxicities?
Dr Marcela Maus
4-minute watch
ASH 2024
Can interim PET aid early identification of patients for CAR T?
Prof. Ran Reshef
5-minute watch
ASH 2024
CAR-Tography: getting a better understanding of acute toxicities post-CAR T
Dr Kai Rejeski
Job code: IHQ-UNB-4903 Date of preparation: October 2023
Job code: IHQ-UNB-4971 Date of preparation: October 2023
Keep up to date
Be the first to find out about Kite Cell Therapy Hub's upcoming content launches
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
Reporting of side effects
If you get any side effects, talk to your doctor or nurse. In the United Kingdom, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.